US-based pharmaceutical company Forest Laboratories has appointed Frank Murdolo as its new vice president of investor relations.
Subscribe to our email newsletter
Mr Murdolo joins Forest following 11 years with GlaxoSmithKline where he was vice president of investor relations, with overall responsibility for managing the North American investor relations program.
Prior to joining GlaxoSmithKline, Mr Murdolo worked for the Schering-Plough as the director of investor relations for six years.
Frank Perier, Jr, CFO of Forest, said: “As the company continues to grow and build its pipeline of products for the future, Frank’s knowledge, experience and reputation will be of great value to the company and its investors.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.